Matrix metalloproteinase-9 and the Cu/Zn ratio as ancillary diagnostic tools in distinguishing between the classical and follicular variants of papillary thyroid carcinoma

Biological Trace Element Research

Volumn 149, Issue 1, 2012, Pages 29-33

  Dragutinović, Vesna V ^a   Tatić, Svetislav B ^a   Nikolić Mandić, Snežana ^b   Savin, Svetlana ^a   Cvejić, Dubravka ^a   Duncrossed D Signerović, Duško ^a   Gajić, Milan ^a   Paunović, Ivan ^a,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Immunohistochemistry; Matrix metalloproteinase 9; Papillary thyroid carcinoma; Trace elements (Cu and Zn)

Indexed keywords

COPPER ION; GELATINASE B; ZINC ION;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER GROWTH; CANCER INVASION; CLASSICAL THYROID CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY, FOLLICULAR; COPPER; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SPECTROPHOTOMETRY, ATOMIC; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT; ZINC;

EID: 84866087650     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-012-9404-y     Document Type: Article

References (28)

1. Al-Brahim N, Asa SL (2006) Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med 130:1057-1062
2. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA (2006) Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of problematic entity. Cancer 107(6):1255-1264
3. Lang BH, Lo CY, Chan WF, Lam AK, Wan KY (2006) Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopatholgic features and long-term outcome. World J Surg 30(5):752-758
4. Passler C, Prager G, Scheuba C, Niederle BE, Kaserer K, Zettinig G, Niederle B (2003) Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138(12):1362-1366
5. Sebastian SO, Gonzales JM, Paricio PP, Perez JS, Flores DP, Madrona AP, Romero PR, Tebar FJ (2000) Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 135(3):272-277
6. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME (2004) Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28(10):1336-1340
7. Liotta LA (1986) Tumor invasion and metastases: role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 46:1-7
8. Liotta LA, Tryggvason K, Garbis S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68
9. Mc Cawley LJ, Matrisian LM (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6(4):149-156
10. Yucel I, Arpaci F, Ozet A, Doner B, Karayilanoglu T, Sayar A, Berk O (1994) Serum copper and zinc levels and copper/zinc ration in patients with breast cancer. Biol Trace Element Res 40:31-38
11. Kokosoy C, Kavas GO, Akcil E, Kocaturk PA, Kara S, Ozarslan C (1997) Trace elements and superoxide dismutase in benign and malignant breast disease. Breast Cancer Res Treat 45:1-4
12. Sobin LH, Wittekind CH (1997) TNM classification of malignant tumours. Wiley-Liss, New York
13. Beesley MF, McLaren KM (2002) Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology 41(3):236-243
14. Volante M, Bozzalla-Casione F, DePompa R, Saggiorato E, Bartolazzi A, Orlandi F, Papotti M (2004) Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Virchows Arch 445(2):183-188
15. Nasir A, Catalano E, Calafati S, Cantor A, Kaiser HE, Coppola D (2004) Role of p53, CD44V6 and CD57 in differentiating between bening and malignant follicular neoplasms of the thyroid. Vivo 18(2):189-195
16. Tomoda C, Kushima R, Takeuti E, Mukaisho K, Hattori T, Kitano H (2003) CD10 expession is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma. Thyroid 13(3):291-295
17. Yegen G, Demir MA, Ertan Y, Nalbant OA, Tuncyurek M (2009) Can CD10 be used as a diagnostic marker in thyroid pathology. Virchows Arch 454:101-105
18. Baldini E, Toller M, Graziano FM, Russo FP, Pepe M, Biordi L, Marchioni E, Curcio F, Ulisse S, Ambesi-Impiombato FS, D'Armiento M (2004) Expession of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines. Thyroid 14:881-888
19. Maeta H, Oghi S, Terada T (2001) Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Arch 438:121-128
20. Thian X, Cong M, Zhou W, Zhu J, Lui Q (2008) Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastases in papillary thyroid cancer. J Int Med Res 36:699-703
21. Kraiem Z, Korem S (2000) Matrix metalloproteinases and the thyroid. Thyroid 10:1061-1069
22. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y (1999) Enhanced production and activation of progelatinase A by membrane type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res 59:467-473
23. Garg AN, Singh V, Weginwar RG, Sagdeo VN (1994) An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis. Biol Trace Element Res 46:185-202
24. Ng KH, Bradley LLM, Mahmood CS, Wood AK (1993) Differentiation of elemental composition of normal and malignant breast tissue by instrumental neutron activation analysis. Appl Radiat Isot 44:511-516
25. Gerber M, Richardson S, Salkeld R, Chappuis P (1991) Antioxidants in female breast cancer patients. Cancer Invest 91:421-428
26. Cavallo F, Gerber M, Marrubini E (1991) Zink and copper in breast cancer. Cancer 67:738-745
27. Zoboli A (1996) A case control study on selenium, zinc and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Element Res 51:23-30
28. Kucharzewski M, Braziewicz J, Majewska U, Gozdz S (2003) Copper, zinc and selenium in whole blood and thyroid tissue of people with various thyroid diseases. Biol Trace Element Res 93:9-18